Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 1
2007 2
2008 1
2010 4
2011 4
2012 6
2013 4
2014 3
2015 4
2016 1
2017 1
2018 3
2019 1
2020 3
2021 3
2023 1
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

36 results

Results by year

Filters applied: . Clear all
Page 1
Multicentric breast cancer with heterogeneous histopathology: a multidisciplinary review.
Corso G, Magnoni F, Provenzano E, Girardi A, Iorfida M, De Scalzi AM, Invento A, Colleoni M, Cassano E, Trentin C, Gullo RL, Pravettoni G, Gilardi L, Grana CM, Intra M, Galimberti V, Veronesi P, De Lorenzi F, Leonardi MC. Corso G, et al. Among authors: iorfida m. Future Oncol. 2020 Mar;16(8):395-412. doi: 10.2217/fon-2019-0540. Epub 2020 Feb 6. Future Oncol. 2020. PMID: 32026709 Review.
Real-world use of multigene signatures in early breast cancer: differences to clinical trials.
Licata L, De Sanctis R, Vingiani A, Cosentini D, Iorfida M, Caremoli ER, Sassi I, Fernandes B, Gianatti A, Guerini-Rocco E, Zambelli C, Munzone E, Simoncini EL, Tondini C, Gentilini OD, Zambelli A, Pruneri G, Bianchini G. Licata L, et al. Among authors: iorfida m. Breast Cancer Res Treat. 2024 May;205(1):39-48. doi: 10.1007/s10549-023-07227-0. Epub 2024 Jan 24. Breast Cancer Res Treat. 2024. PMID: 38265569 Free PMC article.
Management of breast cancer patients during the peak of the COVID 19 pandemic.
Montagna E, Bellerba F, Sangalli C, Gandini S, Cancello G, Aliaga PT, Galimberti V, Leonardi MC, Iorfida M, Munzone E, Mazza M, Dellapasqua S, Mastrilli F, Orecchia R, Malengo D, Omodeo Salè E, Viale G, Rietjens M, Colleoni M, Veronesi P. Montagna E, et al. Among authors: iorfida m. Eur J Surg Oncol. 2021 Oct;47(10):2694-2695. doi: 10.1016/j.ejso.2021.05.037. Epub 2021 May 25. Eur J Surg Oncol. 2021. PMID: 34116901 Free PMC article. No abstract available.
Pegylated Liposomal Doxorubicin (Caelyx®) as Adjuvant Treatment in Early-Stage Luminal B-like Breast Cancer: A Feasibility Phase II Trial.
Dellapasqua S, Trillo Aliaga P, Munzone E, Bagnardi V, Pagan E, Montagna E, Cancello G, Ghisini R, Sangalli C, Negri M, Mazza M, Iorfida M, Cardillo A, Sciandivasci A, Bianco N, De Maio AP, Milano M, Campennì GM, Sansonno L, Viale G, Morra A, Leonardi MC, Galimberti V, Veronesi P, Colleoni M. Dellapasqua S, et al. Among authors: iorfida m. Curr Oncol. 2021 Dec 7;28(6):5167-5178. doi: 10.3390/curroncol28060433. Curr Oncol. 2021. PMID: 34940072 Free PMC article. Clinical Trial.
Invasive lobular breast cancer: subtypes and outcome.
Iorfida M, Maiorano E, Orvieto E, Maisonneuve P, Bottiglieri L, Rotmensz N, Montagna E, Dellapasqua S, Veronesi P, Galimberti V, Luini A, Goldhirsch A, Colleoni M, Viale G. Iorfida M, et al. Breast Cancer Res Treat. 2012 Jun;133(2):713-23. doi: 10.1007/s10549-012-2002-z. Epub 2012 Mar 8. Breast Cancer Res Treat. 2012. PMID: 22399188
Outcome of special types of luminal breast cancer.
Colleoni M, Rotmensz N, Maisonneuve P, Mastropasqua MG, Luini A, Veronesi P, Intra M, Montagna E, Cancello G, Cardillo A, Mazza M, Perri G, Iorfida M, Pruneri G, Goldhirsch A, Viale G. Colleoni M, et al. Among authors: iorfida m. Ann Oncol. 2012 Jun;23(6):1428-36. doi: 10.1093/annonc/mdr461. Epub 2011 Oct 29. Ann Oncol. 2012. PMID: 22039080 Free article.
36 results